Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 1463 entries
View as:

Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05431764 Org: User:
Start: 06/20/22 End: 06/20/26 Due: 06/20/27

Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01815853 Org: User:
Start: 06/30/13 End: 12/31/25 Due: 12/31/26

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT04957901 Org: User:
Start: 12/01/21 End: 06/01/26 Due: 06/01/27

Effects of Different Early Intensive Therapies on Long-term β-cell Function

Phase: N/A Priority: Normal
NCT ID: NCT01471808 Org: User:
Start: 10/31/11 End: 12/31/18 Due: 12/31/19

A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01102517 Org: User:
Start: 01/31/10 End: 12/31/18 Due: 12/31/19

TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06415318 Org: User:
Start: 05/31/24 End: 12/01/27 Due: 12/01/28

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Phase: N/A Priority: Normal
NCT ID: NCT03780049 Org: User:
Start: 10/01/18 End: 10/01/23 Due: 10/01/24

Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)

Phase: N/A Priority: Normal
NCT ID: NCT05453435 Org: User:
Start: 07/15/22 End: 07/31/25 Due: 07/31/26

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03543059 Org: User:
Start: 06/15/18 End: 06/15/23 Due: 06/15/24

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00768157 Org: User:
Start: 04/30/07 End: 08/31/10 Due: 08/31/11

To Discuss the Best Mode for Taking Lapatinib Under the Influence of the Diet

Phase: N/A Priority: Normal
NCT ID: NCT03075995 Org: User:
Start: 04/12/17 End: 04/01/19 Due: 04/01/20

EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)

Phase: N/A Priority: Normal
NCT ID: NCT04072107 Org: User:
Start: 06/01/20 End: 12/01/24 Due: 12/01/25

A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01689350 Org: User:
Start: 10/31/12 End: 03/31/14 Due: 03/31/15

Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05932264 Org: User:
Start: 07/31/23 End: 12/31/25 Due: 12/31/26

Postoperative Pain Management After Minimally Invasive Esophagectomy

Phase: N/A Priority: Normal
NCT ID: NCT02042313 Org: User:
Start: 02/28/14 End: - Due: -

Effect of Prebiotics on Blood Pressure Management

Phase: N/A Priority: Normal
NCT ID: NCT05364736 Org: User:
Start: 10/17/22 End: 12/31/30 Due: 12/31/31

The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT04053985 Org: User:
Start: 01/01/18 End: 12/31/22 Due: 12/31/23

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Phase: N/A Priority: Normal
NCT ID: NCT01347424 Org: User:
Start: 01/31/11 End: 10/31/14 Due: 10/31/15

Satisfaction After Glaucoma Surgery in Rural China

Phase: N/A Priority: Normal
NCT ID: NCT02629237 Org: User:
Start: 03/31/22 End: 10/31/24 Due: 10/31/25

A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03736330 Org: User:
Start: 09/08/18 End: 11/08/21 Due: 11/08/22

Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02681679 Org: User:
Start: 10/31/14 End: 12/31/15 Due: 12/31/16

Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM

Phase: N/A Priority: Normal
NCT ID: NCT06208371 Org: User:
Start: 01/15/24 End: 06/30/29 Due: 06/30/30

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

Phase: N/A Priority: Normal
NCT ID: NCT03493048 Org: User:
Start: 04/15/18 End: 06/30/25 Due: 06/30/26

Psychometric Properties of the Chinese Version of Penn State [Electronic] Cigarette Dependence Index

Phase: N/A Priority: Normal
NCT ID: NCT05477888 Org: User:
Start: 05/27/22 End: 05/30/23 Due: 05/30/24

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Phase: N/A Priority: Normal
NCT ID: NCT02359162 Org: User:
Start: 05/31/15 End: 06/30/17 Due: 06/30/18